Last reviewed · How we verify
Moxifloxacin and Cobicistat — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Moxifloxacin and Cobicistat (Moxifloxacin and Cobicistat) — Food and Drug Administration (FDA).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Moxifloxacin and Cobicistat TARGET | Moxifloxacin and Cobicistat | Food and Drug Administration (FDA) | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Moxifloxacin and Cobicistat CI watch — RSS
- Moxifloxacin and Cobicistat CI watch — Atom
- Moxifloxacin and Cobicistat CI watch — JSON
- Moxifloxacin and Cobicistat alone — RSS
Cite this brief
Drug Landscape (2026). Moxifloxacin and Cobicistat — Competitive Intelligence Brief. https://druglandscape.com/ci/moxifloxacin-and-cobicistat. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab